14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.98 $159.34 Friday, 3rd May 2024 ALNY stock ended at $152.33. This is 1.34% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 2.30% from a day low at $151.91 to a day high of $155.41.
90 days $141.98 $173.18
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Jul 24, 2020 $152.41 $153.47 $148.59 $153.10 281 289
Jul 23, 2020 $159.07 $161.48 $154.13 $154.61 636 059
Jul 22, 2020 $158.42 $159.15 $155.55 $157.98 363 300
Jul 21, 2020 $165.02 $166.48 $157.34 $158.03 684 800
Jul 20, 2020 $164.67 $167.33 $160.17 $165.49 906 100
Jul 17, 2020 $157.36 $161.07 $155.94 $158.36 306 400
Jul 16, 2020 $157.54 $157.83 $153.99 $156.03 275 600
Jul 15, 2020 $157.49 $159.27 $155.73 $158.02 422 700
Jul 14, 2020 $152.74 $157.60 $149.85 $157.23 622 500
Jul 13, 2020 $162.66 $162.89 $152.01 $152.74 666 400
Jul 10, 2020 $157.50 $162.33 $157.30 $162.25 746 700
Jul 09, 2020 $161.00 $161.00 $155.69 $159.03 413 500
Jul 08, 2020 $159.62 $162.57 $156.99 $160.42 836 400
Jul 07, 2020 $153.52 $164.09 $153.52 $160.00 1 360 300
Jul 06, 2020 $149.96 $154.68 $149.37 $152.43 696 300
Jul 02, 2020 $148.87 $151.08 $146.48 $149.87 409 967
Jul 01, 2020 $148.53 $151.39 $147.56 $148.77 479 350
Jun 30, 2020 $148.14 $151.74 $146.09 $148.11 895 713
Jun 29, 2020 $152.27 $152.27 $145.36 $147.91 498 016
Jun 26, 2020 $156.26 $158.37 $150.03 $151.90 2 797 840
Jun 25, 2020 $151.25 $156.44 $150.39 $156.44 806 488
Jun 24, 2020 $151.99 $153.81 $148.58 $151.76 757 406
Jun 23, 2020 $153.51 $156.98 $151.26 $151.83 1 280 036
Jun 22, 2020 $149.96 $153.68 $147.57 $153.00 1 283 339
Jun 19, 2020 $143.70 $150.71 $143.10 $150.71 2 540 443
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT